The risk of breast cancer recurrence is highest 1 to 3 years after surgery

Breast cancer is one of the most common malignant tumors in women. According to statistics, the incidence rate accounts for 7 to 10 percent of all malignant tumors in the body. Its onset is often related to genetics, and the incidence rate is higher in women between the ages of 40 and 60 and before and after menopause. Only about 1 to 2 percent of breast patients are male. It is a malignant tumor that usually occurs in the breast glandular epithelial tissue. It is one of the most common malignant tumors that seriously affects women's physical and mental health and even threatens their lives.

Surgical treatment: Surgical treatment is still the only way to cure breast cancer, so surgical removal of the tumor is the preferred treatment for early breast cancer. The surgical methods for breast cancer have undergone a long evolution. In the past, it was believed that the larger the operation and the more complete the resection, the better the effect. However, this view has changed in recent years. It is advocated to reduce surgical trauma as much as possible while ensuring complete resection, and radical mastectomy and modified radical mastectomy have emerged.

Risk of breast cancer recurrence is highest 1 to 3 years after surgery

Experts believe that the high-risk period for recurrence is within 5 years after breast cancer surgery, and the risk of recurrence is highest within 1 to 3 years after surgery.

Breast cancer recurrence can also have other serious impacts: patients with recurrent breast cancer need additional surgery; more drug treatments are needed, and these drugs may have serious side effects; it also brings a huge economic burden, and more importantly, a huge psychological impact on patients and their families.

At present, there are still many irregularities in actual clinical work. For example, in the treatment of breast cancer, some non-standard treatment methods are used; in the treatment process, the most appropriate drugs are not selected according to the actual situation of the patient; over-treatment and under-treatment coexist; due to various reasons, patients lack knowledge about the treatment, cannot adhere to the treatment, and fail to complete the necessary course of treatment, etc., which will lead to the recurrence of breast cancer.